BestStartup.co.uk is a proud supporter of British business. If you are an investor or looking for a British supplier of exceptional quality offerings this list can provide you with a great starting point.
This article showcases our top picks for the best Coventry based Health Care companies. These startups and companies are taking a variety of approaches to innovating the Health Care industry, but are all exceptional companies well worth a follow.
We tried to pick companies across the size spectrum from cutting edge startups to established brands.
We selected these startups and companies for exceptional performance in one of these categories:
- Innovative ideas
- Innovative route to market
- Innovative product
- Exceptional growth
- Exceptional growth strategy
- Societal impact
Top Coventry Health Care Companies
ScriptSwitch Limited provides prescribing decision support solutions for healthcare professionals within the primary care sector in the UK. ScriptSwitch is the leading provider of software designed to support GPs with patient safety information, drug switch recommendations and dosage optimisation information at the point of prescribing.
It emerged from a small team working out of Warwick University who succeeded in turning their concept into a robust and scalable business.. .
Creavo Medical Technologies
Creavo Medical Technologies Ltd is a UK-based, privately held medical technology company that is developing innovative diagnostic techniques for use in acute medical settings. The company was formed in 2014 by a group of clinical, research and business experts to bring to market technology developed by Professor Ben Varcoe, Chair of Quantum Information Science at Leeds University.
It has facilities in Leeds and Coventry.. .
Mechion is a start-up working on creating autonomous patient observation systems which use Artificial Intelligence in order to provide analytics, insights, quantitative and qualitative data of high value to family members, carers as well as Doctors and Hospitals. They are based in Coventry, UK, home of the British automotive industry and are currently taking part in the StartUpBootcamp accelerator in London.
In Mechion they strongly believe that people with mental and congitive health problems, such as those affected by dementia, should have the opportunity to live in their own homes for as long as it is possible. They understand that people with mild or moderate dementia are still functional human beings and that moving them to hopsitals or clinics creates a lot of stress, anxiety and anguish.
By focusing on the emotional wellbeing and related changes, they believe they can help with healthy ageing, detect important signs and changes and alert family members to intervene or take action. Futhermore, emotional changes are highly correlated with Dementia progression or other mental conditions and should be addressed on time..
Probe Scientific is developing innovative products to solve clinical problems and improve healthcare. The company has a substantial product pipeline based on its proprietary technologies and is seeking to commercialise this range to simultaneously benefit clinicians and the community in general.
Probe Scientific Ltd is a private company, founded in 1998 and is based in the West Midlands, UK. Probe Scientific has grown steadily since its origins as a research organisation and has recently recruited experienced senior executives with a commercial focus..
Swanton Care & Community
Swanton, a specialist provider of residential and supported living care for adults with complex learning disabilities, mental health disorders and acquired brain injuries. Swanton operates 24 specialist residential care homes, providing 259 registered beds across East Anglia, The West Midlands and South West Wales, the North East and Scotland.
Swanton also provides a growing supported living service in its key localities. The company employs around 780 people and generated £25m revenues in the year end..
Incentec Ltd has been developing a predictive diagnostic for pre-eclampsia, a poorly defined condition affecting approximately 6% of first pregnancies. The causes of pre-eclampsia are unknown, although a failure in placental development is thought to be a factor.
There is no diagnostic test currently in use and at the moment, at-risk patients (or suspected cases of pre-eclampsia) are monitored and treated on the basis of observable and developing clinical symptoms.. .
You may write to us at: BestStartup.co.uk/Fupping Ltd, 349 Royal College Street, London, England, NW1 9QS.